Global Apixaban Sales Market Report Forecast 2017-2021

June 2017 | 105 pages | ID: G092E0472DCEN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Pfizer, Inc. (US)
Bayer Healthcare AG (Germany)
GlaxoSmithKline Plc. (UK)
Boehringer Ingelheim (Germany)
Sanofi S.A. (France)
Abbott India Limited (India)
Aspen Holdings (South Africa)
Bristol-Myers Squibb Company (US)
Eisai Inc. (US)

Product Segment Analysis

• Type 1
• Type 2
• Type 3

Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 APIXABAN MARKET OVERVIEW

1.1 Product Overview and Scope of Apixaban
1.2 Classification of Apixaban
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Apixaban
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Apixaban Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Apixaban (2012-2021)
  1.5.1 Global Apixaban Sales and Growth Rate (2012-2021)
  1.5.2 Global Apixaban Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON APIXABAN INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 APIXABAN MANUFACTURING COST ANALYSIS

3.1 Apixaban Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Apixaban

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Apixaban Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Apixaban Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL APIXABAN COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Apixaban Market Competition by Manufacturers
  5.1.1 Global Apixaban Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Apixaban Revenue and Share by Manufacturers (2012-2017)
5.2 Global Apixaban (Volume and Value) by Type
  5.5.1 Global Apixaban Sales and Market Share by Type (2012-2017)
  5.5.2 Global Apixaban Revenue and Market Share by Type (2012-2017)
5.3 Global Apixaban (Volume and Value) by Regions
  5.3.1 Global Apixaban Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Apixaban Revenue and Market Share by Regions (2012-2017)
5.4 Global Apixaban (Volume) by Application

6 UNITED STATES APIXABAN (VOLUME, VALUE AND SALES PRICE)

6.1 United States Apixaban Sales and Value (2012-2017)
  6.1.1 United States Apixaban Sales and Growth Rate (2012-2017)
  6.1.2 United States Apixaban Revenue and Growth Rate (2012-2017)
  6.1.3 United States Apixaban Sales Price Trend (2012-2017)
6.2 United States Apixaban Sales and Market Share by Manufacturers
6.3 United States Apixaban Sales and Market Share by Type
6.4 United States Apixaban Sales and Market Share by Application

7 CHINA APIXABAN (VOLUME, VALUE AND SALES PRICE)

7.1 China Apixaban Sales and Value (2012-2017)
  7.1.1 China Apixaban Sales and Growth Rate (2012-2017)
  7.1.2 China Apixaban Revenue and Growth Rate (2012-2017)
  7.1.3 China Apixaban Sales Price Trend (2012-2017)
7.2 China Apixaban Sales and Market Share by Manufacturers
7.3 China Apixaban Sales and Market Share by Type
7.4 China Apixaban Sales and Market Share by Application

8 EUROPE APIXABAN (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Apixaban Sales and Value (2012-2017)
  8.1.1 Europe Apixaban Sales and Growth Rate (2012-2017)
  8.1.2 Europe Apixaban Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Apixaban Sales Price Trend (2012-2017)
8.2 Europe Apixaban Sales and Market Share by Manufacturers
8.3 Europe Apixaban Sales and Market Share by Type
8.4 Europe Apixaban Sales and Market Share by Application

9 JAPAN APIXABAN (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Apixaban Sales and Value (2012-2017)
  9.1.1 Japan Apixaban Sales and Growth Rate (2012-2017)
  9.1.2 Japan Apixaban Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Apixaban Sales Price Trend (2012-2017)
9.2 Japan Apixaban Sales and Market Share by Manufacturers
9.3 Japan Apixaban Sales and Market Share by Type
9.4 Japan Apixaban Sales and Market Share by Application

10 GLOBAL APIXABAN MANUFACTURERS ANALYSIS

10.1 Pfizer, Inc. (US)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Bayer Healthcare AG (Germany)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 GlaxoSmithKline Plc. (UK)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Boehringer Ingelheim (Germany)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Sanofi S.A. (France)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Abbott India Limited (India)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Aspen Holdings (South Africa)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Bristol-Myers Squibb Company (US)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Eisai Inc. (US)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL APIXABAN MARKET FORECAST (2017-2021)

13.1 Global Apixaban Sales, Revenue Forecast (2017-2021)
13.2 Global Apixaban Sales Forecast by Regions (2017-2021)
13.3 Global Apixaban Sales Forecast by Type (2017-2021)
13.4 Global Apixaban Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES


FIGURE PICTURE OF APIXABAN

Table Classification of Apixaban
Figure Global Sales Market Share of Apixaban by Type in 2015
Table Applications of Apixaban
Figure Global Sales Market Share of Apixaban by Application in 2015
Figure United States Apixaban Revenue and Growth Rate (2012-2021)
Figure China Apixaban Revenue and Growth Rate (2012-2021)
Figure Europe Apixaban Revenue and Growth Rate (2012-2021)
Figure Japan Apixaban Revenue and Growth Rate (2012-2021)
Figure Global Apixaban Sales and Growth Rate (2012-2021)
Figure Global Apixaban Revenue and Growth Rate (2012-2021)
Table Global Apixaban Sales of Key Manufacturers (2012-2017)
Table Global Apixaban Sales Share by Manufacturers (2012-2017)
Figure 2015 Apixaban Sales Share by Manufacturers
Figure 2016 Apixaban Sales Share by Manufacturers
Table Global Apixaban Revenue by Manufacturers (2012-2017)
Table Global Apixaban Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Apixaban Revenue Share by Manufacturers
Table 2016 Global Apixaban Revenue Share by Manufacturers
Table Global Apixaban Sales and Market Share by Type (2012-2017)
Table Global Apixaban Sales Share by Type (2012-2017)
Figure Sales Market Share of Apixaban by Type (2012-2017)
Figure Global Apixaban Sales Growth Rate by Type (2012-2017)
Table Global Apixaban Revenue and Market Share by Type (2012-2017)
Table Global Apixaban Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Apixaban by Type (2012-2017)
Figure Global Apixaban Revenue Growth Rate by Type (2012-2017)
Table Global Apixaban Sales and Market Share by Regions (2012-2017)
Table Global Apixaban Sales Share by Regions (2012-2017)
Figure Sales Market Share of Apixaban by Regions (2012-2017)
Figure Global Apixaban Sales Growth Rate by Regions (2012-2017)
Table Global Apixaban Revenue and Market Share by Regions (2012-2017)
Table Global Apixaban Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Apixaban by Regions (2012-2017)
Figure Global Apixaban Revenue Growth Rate by Regions (2012-2017)
Table Global Apixaban Sales and Market Share by Application (2012-2017)
Table Global Apixaban Sales Share by Application (2012-2017)
Figure Sales Market Share of Apixaban by Application (2012-2017)
Figure Global Apixaban Sales Growth Rate by Application (2012-2017)
Figure United States Apixaban Sales and Growth Rate (2012-2017)
Figure United States Apixaban Revenue and Growth Rate (2012-2017)
Figure United States Apixaban Sales Price Trend (2012-2017)
Table United States Apixaban Sales by Manufacturers (2012-2017)
Table United States Apixaban Market Share by Manufacturers (2012-2017)
Table United States Apixaban Sales by Type (2012-2017)
Table United States Apixaban Market Share by Type (2012-2017)
Table United States Apixaban Sales by Application (2012-2017)
Table United States Apixaban Market Share by Application (2012-2017)
Figure China Apixaban Sales and Growth Rate (2012-2017)
Figure China Apixaban Revenue and Growth Rate (2012-2017)
Figure China Apixaban Sales Price Trend (2012-2017)
Table China Apixaban Sales by Manufacturers (2012-2017)
Table China Apixaban Market Share by Manufacturers (2012-2017)
Table China Apixaban Sales by Type (2012-2017)
Table China Apixaban Market Share by Type (2012-2017)
Table China Apixaban Sales by Application (2012-2017)
Table China Apixaban Market Share by Application (2012-2017)
Figure Europe Apixaban Sales and Growth Rate (2012-2017)
Figure Europe Apixaban Revenue and Growth Rate (2012-2017)
Figure Europe Apixaban Sales Price Trend (2012-2017)
Table Europe Apixaban Sales by Manufacturers (2012-2017)
Table Europe Apixaban Market Share by Manufacturers (2012-2017)
Table Europe Apixaban Sales by Type (2012-2017)
Table Europe Apixaban Market Share by Type (2012-2017)
Table Europe Apixaban Sales by Application (2012-2017)
Table Europe Apixaban Market Share by Application (2012-2017)
Figure Japan Apixaban Sales and Growth Rate (2012-2017)
Figure Japan Apixaban Revenue and Growth Rate (2012-2017)
Figure Japan Apixaban Sales Price Trend (2012-2017)
Table Japan Apixaban Sales by Manufacturers (2012-2017)
Table Japan Apixaban Market Share by Manufacturers (2012-2017)
Table Japan Apixaban Sales by Type (2012-2017)
Table Japan Apixaban Market Share by Type (2012-2017)
Table Japan Apixaban Sales by Application (2012-2017)
Table Japan Apixaban Market Share by Application (2012-2017)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer, Inc. (US) Apixaban Global Market Share (2012-2017)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Healthcare AG (Germany) Apixaban Global Market Share (2012-2017)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc. (UK) Apixaban Global Market Share (2012-2017)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim (Germany) Apixaban Global Market Share (2012-2017)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi S.A. (France) Apixaban Global Market Share (2012-2017)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott India Limited (India) Apixaban Global Market Share (2012-2017)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aspen Holdings (South Africa) Apixaban Global Market Share (2012-2017)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company (US) Apixaban Global Market Share (2012-2017)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Inc. (US) Apixaban Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Apixaban
Figure Manufacturing Process Analysis of Apixaban
Figure Apixaban Industrial Chain Analysis
Table Raw Materials Sources of Apixaban Major Manufacturers in 2015
Table Major Buyers of Apixaban
Table Distributors/Traders List
Figure Global Apixaban Sales and Growth Rate Forecast (2017-2021)
Figure Global Apixaban Revenue and Growth Rate Forecast (2017-2021)
Table Global Apixaban Sales Forecast by Regions (2017-2021)
Table Global Apixaban Sales Forecast by Type (2017-2021)
Table Global Apixaban Sales Forecast by Application (2017-2021)